Humira Biosimilar Market – Overview & Growth Outlook
Humira Biosimilar Market Size is Valued at USD 0.72 Billion in 2023, and is Projected to Reach USD 4.34 Million by 2032, Growing at a CAGR of 22.1% From 2024-2032.
Humira biosimilar market define the part of pharmeducial industry that is involved in the production of biosimilar drugs which are intended to be used to offer similar therapeutic effects to the Humira that is adalimumab biologic which is used for the treatment of autoimmune diseases including rheumatoid arthritis, psoriasis, and inflammatory bowel disease.